Q4 Earnings Forecast for Edap Tms Issued By HC Wainwright

Edap Tms S.A. (NASDAQ:EDAP) – HC Wainwright issued their Q4 2026 earnings per share (EPS) estimates for shares of Edap Tms in a report issued on Friday, May 16th. HC Wainwright analyst S. Ramakanth expects that the medical equipment provider will post earnings of ($0.08) per share for the quarter. HC Wainwright has a “Buy” rating and a $19.00 price target on the stock. The consensus estimate for Edap Tms’ current full-year earnings is ($0.60) per share. HC Wainwright also issued estimates for Edap Tms’ FY2029 earnings at $0.31 EPS.

Several other research analysts have also recently weighed in on the company. Piper Sandler cut Edap Tms from an “overweight” rating to a “neutral” rating in a report on Thursday, May 15th. StockNews.com initiated coverage on Edap Tms in a report on Thursday, May 15th. They set a “hold” rating on the stock. Finally, Jefferies Financial Group restated a “hold” rating and set a $2.00 target price (down from $8.00) on shares of Edap Tms in a report on Friday, April 4th.

Edap Tms Trading Up 5.7%

Shares of Edap Tms stock opened at $1.86 on Monday. The stock has a market cap of $69.55 million, a P/E ratio of -2.86 and a beta of 0.13. The stock’s 50 day simple moving average is $1.91 and its 200-day simple moving average is $2.23. Edap Tms has a 1-year low of $1.26 and a 1-year high of $6.70. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46.

Edap Tms (NASDAQ:EDAP) last posted its quarterly earnings data on Thursday, May 15th. The medical equipment provider reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by ($0.04). Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%.

Institutional Trading of Edap Tms

Several institutional investors have recently made changes to their positions in EDAP. Banque Transatlantique SA raised its position in shares of Edap Tms by 7,063.7% during the 1st quarter. Banque Transatlantique SA now owns 730,699 shares of the medical equipment provider’s stock valued at $1,324,000 after buying an additional 720,499 shares during the period. Scoggin Management LP purchased a new stake in Edap Tms in the first quarter valued at approximately $686,000. Jane Street Group LLC raised its position in Edap Tms by 174.7% in the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock valued at $69,000 after purchasing an additional 73,361 shares during the period. Schonfeld Strategic Advisors LLC raised its position in Edap Tms by 48.5% in the fourth quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock valued at $355,000 after purchasing an additional 52,500 shares during the period. Finally, Millennium Management LLC raised its position in Edap Tms by 218.5% in the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock valued at $108,000 after purchasing an additional 33,558 shares during the period. Hedge funds and other institutional investors own 62.74% of the company’s stock.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.